MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Drug-induced parkinsonism(DIP)"

  • 2026 International Congress

    Delayed-Onset Rapidly Progressive Parkinsonism After BCMA×CD3 Bispecific Antibody Therapy: A Case Report

    IF. Yang, TY. Chung, YF. Sung (Taipei, Taiwan)

    Objective: To describe a delayed-onset rapidly progressive parkinsonian syndrome with encephalopathy following BCMA×CD3 bispecific antibody therapy. Background: B-cell maturation antigen (BCMA) × CD3 bispecific antibodies…
  • 2026 International Congress

    Parkinsonism in B-Cell Maturation Antigen-Targeting CAR-T Cell Cancer Therapies

    A. Zolin, V. Gao, D. Riegel, C. Snajdr-Trinch, B. Santomasso, R. Magge, S. Wesley, H. Danish, H. Sarva, H. Ooi, A. Yoo (New York, USA)

    Objective: Describe parkinsonism after B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor (CAR) T-cell therapy for treatment of multiple myeloma. Background: BCMA-targeted CART-cell therapy effectively treats…
  • 2026 International Congress

    Late Diagnosed Kufor Rakeb Syndrome Presenting as Drug Induced Parkinsonism

    MG. Gultekin (Kayseri, Turkey)

    Objective: Kufor-Rakeb syndrome (KRS) may present with a wide variety of psychiatric symptoms. This case describes the development of parkinsonism after antipsychotic treatment and the…
  • 2026 International Congress

    Methanol Intoxication Presenting as a Mixed Ataxic-Parkinsonian Syndrome With a Paradoxical Response to Levodopa: A Case Report

    D. Solorzano Gomez (Huánuco, Peru)

    Objective: To report a case of methanol-induced mixed cerebellar and parkinsonian sequelae, emphasizing the pathophysiological mechanisms underlying the neuroimaging findings and the paradoxical response to…
  • 2026 International Congress

    Comparison of Motor Severity in Individuals with Drug-Induced Parkinsonism and Idiopathic Parkinson’s Disease A Systematic Review and Meta-Analysis

    E. Maciel, T. da Rosa, F. Pereira, P. Nepomuceno, A. Pagnussat (Porto Alegre, Brazil)

    Objective: To compare motor severity between individuals with drug-induced Parkinsonism (DIP) and idiopathic Parkinson’s disease (iPD) Background: DIP and iPD may present with similar motor…
  • 2026 International Congress

    Neuroprotective Effects of Emodin Against Rotenone-Induced Parkinsonism Through Regulation of SIRT1-Mediated Inflammasome and Nrf2 Pathways

    A. Kumar (Prayagraj, India)

    Objective: This study aimed to investigate the neuroprotective potential of emodin in a rotenone-induced PD model and to elucidate its underlying molecular mechanisms focusing on…
  • 2026 International Congress

    PEST-PD: Preliminary Findings from an Ongoing Longitudinal Observational Study for Prodromal Parkinson’s disease in farmers exposed to pesticides.

    E. Cubo, L. Gomez-Cuadrado, D. Garcia-Garcia, A. Canepa, B. Alonzo-Nuñez, D. de Lara (Burgos, Spain)

    Objective: To compare the risk for prodromal Parkinson's disease (PD) in subjects exposed and non-exposed to pesticides Background: Farmers may have an elevated risk of…
  • 2026 International Congress

    The Lentiform Fork Sign: Acute Parkinsonism in a Dialysis Patient with Metformin Misuse

    J. Haddad Labello, B. Souza Telho, J. Cavalcanti, R. Bernhart Carra, J. Bezerra Parmera (Sao Paulo, Brazil)

    Objective: To report a rare case of the Lentiform Fork Sign associated with acute parkinsonism in a patient with end-stage renal disease and metformin-associated lactic acidosis. Background: The Lentiform Fork Sign is a rare neuroradiological finding characterized by bilateral T2/FLAIR hyperintensities in the basal ganglia outlining the internal and external capsules (1). It has been most commonly described in patients with end-stage renal disease and is typically associated with metabolic acidosis. The proposed mechanism involves cerebral acidosis leading to vasogenic and/or cytotoxic edema in metabolically vulnerable regions such as the basal ganglia (2). Method: We report a 43-year-old man with end-stage renal disease on hemodialysis and type 2 diabetes mellitus who presented with…
  • 2026 International Congress

    Baclofen-Induced Worsening of Parkinsonism in a Patient with CADASIL and Brainstem Stroke

    Y-H. Wu (Taipei, Taiwan)

    Objective: To report baclofen-associated worsening of parkinsonism in a patient with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and recent brainstem infarction,…
  • 2026 International Congress

    Neuroprotective and Antiparkinsonian Effects of Green-Synthesized Silver Nanoparticles from Eclipta prostrata in a Haloperidol-Induced Murine Model

    S. Rajput, P. Tiwari, S. Sinha (Delhi, India)

    Objective: To evaluate the antiparkinsonian efficacy of silver nanoparticles synthesized from Eclipta prostrata (SEP) in a haloperidol-induced murine model of Parkinson's disease (PD). Background: Eclipta…
  • 1
  • 2
  • 3
  • …
  • 11
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley